HealthEquity Reports First Quarter Ended April 30, 2024 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/5/2026
- Equities close higher as softer jobs data quiets rate-hike expectations
- U.S. economy adds fewer jobs than expected as unemployment rate ticks higher
- Nvidia returns as Morgan Stanley’s Top Pick on attractive valuation
- Citi says rate volatility without Fed repricing is concerning
- U.S. credit-reporting stocks fall as FHFA weighs two-bureau mortgage rule
- Equities close higher as softer jobs data quiets rate-hike expectations
- Cantor Fitzgerald on Rivian (RIVN): 'pre-announced that it delivered 19,248 vehicles in 3Q26, above our estimate'
- DISH DBS emerges from bankruptcy, cuts debt by $4.35 billion
- Nvidia returns as Morgan Stanley’s Top Pick on attractive valuation
- Tanker struck by projectile in Strait of Hormuz
Jefferies Reiterates Buy Rating on HealthEquity, Inc (HQY)
June 3, 2024 4:33 PM EDTJefferies analyst Glen Santangelo reiterated a Buy rating and $95.00 price target on HealthEquity, Inc (NASDAQ: HQY)
The analyst comments "HQY reported another exceptional qtr with revs and EBITDA comfortably ahead. The company is executing well, benefitting from strong HSA sales, greater utilization of... More
